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Purpose: There is growing interest in the provision of trial results to trial participants. However, there are
a number of gaps in the research base relating to the closure of clinical trials and feedback of results to
participants.
Methods: The aim of this research was to explore the practice of feeding back trial results to trial
participants and to identify best practice in this area. Postal questionnaires were sent to members of the
UK National Cancer Research Institute Clinical Studies Groups (NCRI CSG) and to patients over the age of
18 years who completed trial treatment (located in one Cancer Network) during a 16-month period
(April 07eJuly 08).
Results: 145 NCRI CSG member surveys and 81 patient questionnaires were returned. The vast majority of
all respondents supported the idea of offering results to trial participants. However, NCRI members and
trial participants differed in their opinions about the timing and method for the provision of results.
Conclusion: The results provide an insight into the views of these groups in relation to desire for results
and practical aspects of results feedback which should inform further investigations into trial manage-
ment and the practice of feedback of trial results.
 2010 Elsevier Ltd. Open access under CC BY-NC-ND license. Background
There is growing interest in the provision of trial results to trial
participants. A review by Shalowitz and Miller (2008) examined 28
studies which explored the practice of results feedback and
reported overall that there was considerable evidence that those
who took part in trials would like to receive the results of those
trials (for examples of these studies see Partridge et al., 2003;
Moutel et al., 2005; Fernandez et al., 2007). In addition, there was
some evidence that those responsible for clinical trials supported
the return of results to those who took part (for examples of these
studies see Di Blasi et al., 2002; Fernandez et al., 2003; Partridge
et al., 2004). While there appears to be a desire to receive results
and an increasing acceptance of the necessity of providing them,
there remains a lack of information in relation to the actual practice
of results feedback and the barriers and facilitators relating to
results feedback.
This paper presents the ﬁndings from a piece of work that was
designed to survey both clinicians and patients involved in a broad8202.
ox).
-NC-ND license. spectrum of UK cancer trials, about their views of, attitudes
towards, current practice in and experiences of, the feedback of trial
results. The knowledge base developed provides an insight into the
views of these groups in relation to desire for results and practical
aspects of results feedback which should inform further investi-
gations into trial management and the practice of feedback of trial
results.
Methods
The aim of this research was to explore the practice of feeding
back trial results to thosewho take part in cancer trials. A number of
objectives were developed in order to clarify this aim. These were:
 To investigate attitudes towards the feedback of trial results
 To identify barriers and facilitators associated with trial results
feedback
 To identify areas of best practice
 To identify future areas of research in relation to effective and
appropriate feedback of trial results.
In order to meet this aim and these objectives it was identiﬁed
that a postal questionnaire survey targeting both clinicians and
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on the basis of a targeted literature review relating to feedback of
trial results. Drawing on the ﬁndings of this review, survey items
were generated and reﬁned by the research team; efforts were
made to construct items that could be administered to both NCRI
and patient respondents (in parallel forms). Draft versions of each
questionnaire were piloted with NCRI members and a patient
forum (for NCRI and patient formats respectively), and items were
adjusted on the basis of this feedback. The survey included closed
and open questions and short and long answer formats to elicit
responses about the ethical, practical, and attitudinal issues
associated with feedback of trial results to study participants.
Relevant ethical and NHS Trust approvals were obtained for the
survey work.
In order to target clinicians involved in clinical trials the survey
was sent to members of the 21 UK National Cancer Research
Institute Clinical Studies Groups (NCRI CSG), including 15 cancer-
site speciﬁc groups and ﬁve generic groups and the Consumer
Liaison Group. The survey was distributed at group meetings or
posted/emailed out to those not present. The patient survey was
sent to patients over the age of 18 years (located in one Cancer
Network) who had completed a range of identiﬁed trial treatments
(i.e. chemotherapy, radiotherapy, hormone therapy, surgery)
during a 16-month period (April 07eJuly 08). A questionnaire pack
was mailed to eligible patients via the network trials staff at each of
the participating hospitals who managed the trial databases and
checked patients were eligible for the study. Questionnaires were
returned to the research team via pre-paid envelopes.
Data analysis
Responses were summarised using descriptive analyses in SPSS.
The Fisher exact test and ManneWhitney U test were used to
compare NCRI and patient responses. This paper presents a selec-
tion of the ﬁndings from these questionnaires.
Results
Respondent characteristics
Table 1 shows characteristics of survey respondents. In total, 145
NCRI CSG member surveys were returned, representing 32.5% of
the target population (446); 120 returns were from professional
members of the NCRI CSGs and 25 were from consumer members.
Most professional member respondents (80.5%) had experience of
being the principal investigator on a clinical trial. A minority of
professional and consumer members had experience of serving on
an ethics committee. A further 81 patient surveys were returned
representing 52% of the target population (157).Table 1
Characteristics of survey respondents.
Characteristic NCRI CSG members
Professional
(total N¼ 120)
Co
(to
Gender Valid n¼ 114 Va
% Female 36.8 64
% Male 63.2 36
Age Valid n¼ 112 Va
Mean (SD) 47.8 (7.2) 56
Served on ethics committee? Valid n¼ 114 Va
% Yes 25.4 8.0
Been PI on a clinical trial? Valid n¼ 113 Va
% Yes 80.5 0.0Should trial results be offered?
Both surveys included the question ‘should trial participants
be offered a lay summary of results?’ The principle of offering
results was broadly supported by both groups of survey respon-
dents. Of the 141 NCRI CSG members who responded to this
question, the majority (134; 95%) indicated that trial participants
should be offered a lay summary of the trial’s results. Only two
respondents (1.4%) indicated that trial participants should not be
offered a summary of results. Of the 79 patients who responded to
this question; the majority (78; 98.7%) indicated that trial partici-
pants should be offered a lay summary of trial results. One
respondent (1.3%) stated that trial results should not be offered to
participants. There was no signiﬁcant difference between NCRI and
patient respondents in responses to this question (Fisher’s exact
test, p¼ .25).
Managing the provision of feedback
Both surveys explored various alternatives for when and how to
communicate results. Respondents were asked to select all options
that they supported (by ticking appropriate boxes) and to specify
(by free text response) the person/method for information delivery
that they considered to be best. Table 2 presents response
frequencies/proportions by respondent type.
The most frequently endorsed option amongst NCRI CSG
members for when to share results with participants was at a point
after the whole trial has closed (selected by 127 respondents;
representing 89.4% of those responding to the question). Within
this broad category (post-closure), the time of publication was the
most frequently supported time-point for feedback provision (101;
71.1%). In contrast to this, the most frequently selected option
amongst patients for when to share results with participants was to
provide regular updates of the trial’s progress, (46; 58.2%).
However, a substantial proportion of NCRI CSG member respon-
dents (60; 42.3%) also endorsed a system of regular information
updates.
Examination of responses by respondent type indicated that
NCRI and patient respondents differed signiﬁcantly in their pref-
erences around timing of results feedback (Fisher’s exact tests, all
ps< .001). Patient respondents were more likely than NCRI
respondents to endorse both (1) feedback of ‘results to date’ to
individuals as they end trial participation and (2) regular infor-
mation updates regarding trial progress. It may be that NCRI
respondents had greater concerns about releasing information
before it is ﬁnalised and/or the practical demands of providing
interim/regular information updates.
None of the options presented for how to distribute results to
participants were endorsed by a majority of NCRI CSG members.Patients
(total N¼ 81)
nsumer
tal N¼ 25)
Combined
(total N¼ 145)
lid n¼ 25 Valid n¼ 139 Valid n¼ 80
.0 41.7 37.5
.0 58.3 62.5
lid n¼ 25 Valid n¼ 137 Valid n¼ 80
.0 (9.4) 49.3 (8.3) 63.9(11.3)
lid n¼ 25 Valid n¼ 139
22.3 Na
lid n¼ 25 Valid n¼ 138
65.9 Na
Table 2
Support for different options around management of feedback provision.
NCRI respondent
support (1)
Patient respondent
support (2)
Difference
(¼1e2)
95% CI (diff)
Lower Upper
Timing of results feedback
Results should be given to patients at a point after the
whole trial has closed (all data collected)a
89.4% (127/142) 44.3% (35/79) 45.1%* 32.6% 56.3%
A summary of ‘results to date’ should be given to
patients at the point at which they leave the study
23.2% (33/142) 51.9% (41/79) 28.7%* 41.0% 15.4%
Regular updates of the trial’s progress should be
provided to patients who wish to receive them
42.3% (60/142) 58.2% (46/79) 16.0%* 28.9% 2.2%
Method of results feedback
Results are given to patients by their clinician, face-to-face 49.0% (70/143) 58.0% (47/81) 9.1% 22.0% 4.5%
Results are given to patients by a nurse, face-to-face 35.0% (50/143) 22.2% (18/81) 12.7%* 0.2% 23.9%
Results are given to patients by a member of the
research team, face-to-face
37.8% (54/143) 44.4% (36/81) 6.7% 19.9% 6.5%
Results are posted to patients when they are available 46.2% (66/143) 45.7% (37/81) 0.5% 12.9% 13.7%
Results are emailed to patients when they are available 21.0% (30/143) 18.5% (15/81) 2.5% 9.0% 12.6%
Patients receive a letter to say results are available,
and are given a telephone number to request them
49.7% (71/143) 9.9% (8/81) 39.8%* 28.1% 49.2%
Patients receive a letter to say results are available online,
and are given a link to the appropriate web address
48.3% (69/143) 21.0% (17/81) 27.3%* 14.4% 38.3%
*Signiﬁcant difference at p< .05. NoteDifference shows the difference in proportions between sub-groups .95% conﬁdence intervals for these differences were calculated using
Newcombe methods (Newcombe, 1998). Where conﬁdence intervals do not cross 0%, proportional differences are statistically signiﬁcant at p< .05.
a This response category included more speciﬁc sub-options for NCRI respondents, but not patient respondents.
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CSGmember respondents, was for patients to receive a letter which
indicates that results are available and provides a number to call to
request them. Patient respondents most frequently selected that
results should be given to patients by their doctor, face-to-face (47;
58.0%).
Formal comparisons of NCRI and patient responses indicated
that respondents signiﬁcantly differed in their perception of the
acceptability of three distribution methods. The option of notifying
patients by letter that results can be requested by phone was less
popular with patient respondents than NCRI respondents (Fisher’s
exact test, p< .001). Similarly, patient respondents were less
supportive of a parallel option e notifying patients by letter that
results can be accessed online e as compared with NCRI respon-
dents (Fisher’s exact test, p< .001). NCRI respondents were more
supportive of face-to-face provision of results by a nurse, as
compared with patient respondents (Fisher’s exact test, p¼ .050).
No other signiﬁcant differences were observed with regard to
supported distribution methods.
Offering results to next of kin
NCRI CSG members and patients were both asked to consider
whether results should be offered to the next of kin of deceased
patients. Of 143 NCRI CSG members who responded to this ques-
tion, 76 (53.1%) indicated that the next of kin should be offered
results. Of the 81 patient responses to this question, 56 (69.1%)
indicated that patient’s next of kin should be offered results. Forty
one NCRI CSG member respondents (28.7%) indicated that next of
kin should not be offered results, and 26 (18.2%) selected the ‘don’t
know’ response option. Eighteen patient respondents (22.2%)
indicated that next of kin should not be offered results and seven
(8.6%) selected the ‘don’t know’ response option. Formal compar-
ison indicated that response proportions differed between
respondents (Fisher’s exact test, p¼ .043) with patient respondents
being more supportive of offering results to next of kin.
Attitudes towards results feedback
Both surveys contained a section to assess the attitude of
respondents towards a variety of statements; responses wereprovided on a 5-point ordinal scale, with high scores indicating
greater agreement with the statement. The NCRI CSG member and
patient responses are presented as box plots in Fig. 1.
Mann-Whitney U tests were carried out for each statement,
comparing NCRI member and patient agreement. Patient respon-
dents tended towards stronger agreement with the statements
‘most patients want to know the results of trials inwhich they have
taken part’ (p< .001), ‘most patients understand the potential
effects and implications of receiving trial results’ (p< .001), ‘there
should be an informed consent process around the offer of trial
results’ (p< .001) and ‘routinely offering trial results would
increase patient trust in professionals’ (p< .001).
Possible disadvantages of offering feedback
Free text questions on both surveys asked respondents to
comment on the possible disadvantages of offering trial feedback.
As a broad category, negative psychological impact on patients and
carers was the most frequently reported potential drawback of
offering/providing results: present in 109/135 NCRI CSG sources
(80.7%) and 34/67 patient sources (50.7%). Within this category,
effects of negative results/bad news (e.g., of side effects or being in
the inferior arm) were the dominant concern. Twelve NCRI CSG
respondents (8.8%) and twenty ﬁve patient respondents (39.6%)
indicated that they perceived no real disadvantages to offering
feedback.
Facilitating the practice of results feedback
Respondents were asked to suggest factors that would help to
facilitate the practice of feeding back results to participants (free
text response). Within the NCRI CSG member responses the most
frequently identiﬁed facilitator of feedback practice was to intro-
duce the concept at the point of trial entry (41/125 sources, 32.8%)
such that informed consent about feedback (and identiﬁcation of
associated preferences) can be obtained at an early stage. A process
of normalisation/cultural shift (such that feedback becomes an
expectation) was identiﬁed as a facilitator by 23 respondents
(18.4%); the same number of respondents identiﬁed extra resources
as a facilitator. A system for data-tracking and long-term follow-up
(with implicit resource implications) was identiﬁed as facilitating
Fig. 1. Box plots of statement agreement by respondent type. *Signiﬁcant difference at p< .05. Note. For the box plots, error bars show the minimum and maximum values, boxes
show the interquartile range, and horizontal lines show the median.
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that compulsion (by ethics regulators or funders) would be most
effective.
The patient questionnaire asked ‘what do you think would help
to encourage the practice of offering results to trial participants?’
Many respondents (24/53, 45.3%) did not answer the question
posed, instead they provided a variety of responses ranging from
how trial participants themselves might be encouraged to ask for
results, to statements of belief about the rights of all participants to
be offered results. Four respondents (7.5%) expressed uncertainty
over the question, one wrote “Don’t understand the question. If it is
part of the procedure to offer results why do researchers need
encouraging? It is part of the task, part of the job, isn’t it?” Twelve
responses did relate to ways of encouraging the practice of offering
results and suggested that, offering results should be made
a routine part of clinical trials (4/53, 7.5%), helping staff to under-
stand why patients want feedback (4/53, 7.5%), the introduction of
a ﬁnancial incentive for research centres to provide feedback (3/53,
5.7%) and the provision of extra staff to cope with the additional
workload (1/53, 1.9%).
Personal experience of being offered trial results
The patient survey asked trial participants if they had been
offered the opportunity to receive feedback about the trial inwhich
they had taken part. A large majority (68/79, 86.1%) indicated that
they had not been asked, 8.9% (7/79) indicated that they had been
asked and 5.1% (4/79) were unsure. Two participants did not
answer this question. Respondents who indicated that they had
been offered the opportunity to receive results were subsequently
asked to specify (by free text response) who had asked them, whathad they been told, and whether there was anything else they
wanted to know about the trial. Eight trial participants provided
further information about trial feedback that they had received. The
feedback had been offered to them by either a doctor, a nurse or
other member of the research team. One individual commented
that the consent form that they signed at the start of the trial asked
whether the participant wanted to receive feedback after the trial.
Several individuals had yet to receive any information about the
trial and only one individual stated that there was nothing else they
still wanted to know in relation to the trial.
All respondents were asked if they wanted to know the results
of the trial in which they took part. A substantial majority (69/78,
88.5%) indicated that they did want to know the results of the
trial in which they had taken part. 5.1% (4/78) did not want to
know the results and 6.4% (5/78) were unsure. Respondents who
indicated that they would like to receive trial results were
subsequently asked to specify (by free text response) what in
particular they would like to know. The responses indicated that
some individuals desired personal results, others wanted to know
the overall ﬁndings and many wanted to know both of these
things. A closed response question also asked respondents about
the kind of trial feedback that they would like to receive. 70.4%
(57/81) indicated that they would want a summary of overall
ﬁndings and 69.1% (56/81) indicated that they would like per-
sonalised feedback with individual implications (respondents
could endorse more than one response option). Cross tabulating
responses to this question: 35 respondents (43.2%) indicated that
they would want both overall and individualised ﬁndings; 22
respondents (27.2%) would want overall but not individualised
ﬁndings; and 21 respondents (25.9%) would want individualised
but not overall ﬁndings.
K. Cox et al. / European Journal of Oncology Nursing 15 (2011) 124e129128All respondents were then asked ‘if the results of your trial did
not show any beneﬁt, would youwant to be given a summary of the
(negative) results? The majority of respondents (68/81, 84.0%)
indicated that in this situation they still wanted to receive the trial
results. 9.9% (8/81) did not want negative results and 6.2% (5/81)
were unsure.
Discussion
Consistent with previous studies (for example Partridge et al.,
2005; Fernandez et al., 2009; Sood et al., 2009) this research
identiﬁed that a majority of patients desire results feedback.
Similarly the study also identiﬁed a high level of support for
feedback from those involved in running clinical trials. 95% of NCRI
group member respondents expressed support for the concept of
offering trial results to participants. This is a more emphatic
expression of support than previous studies exploring investigator
support for results communication have identiﬁed (Partridge et al.,
2004; Rigby and Fernandez, 2005; Di Blasi et al., 2002) and may
reﬂect a growing awareness of the desires and rights of trial
participants. Despite this it appears that translating the concept of
offering results into the practice of offering results is proving
difﬁcult and in this survey over 80% of trial participant respondents
reported they had not been offered any feedback of trial results.
The survey data from NCRI members indicated that despite
supporting the concept of offering trial results clinicians continue
to have concerns about the implications and practicalities of
offering trial results. Over 80% of NCRI group member respondents
reported concern over the potential negative psychological impact
on participants of receiving trial results. 50.7% of patient respon-
dents also indicated that they were aware that results feedback
might be distressing or painful, however, many patient respondents
indicated that they wanted the results despite this and some sug-
gested that the satisfaction of knowing more about the trial was
more important to them than the potential distress that hearing
bad news might cause. Several studies have examined whether
participants who have received results found them distressing,
frightening or alarming. There is some evidence to suggest that
receiving results can cause distress for a minority of individuals
however this does not appear to consistently translate into regret
about receiving results (Dixon-Woods et al., 2006; Partridge et al.,
2005, 2009; Schulz et al., 2003). Further research is required
which speciﬁcally examines the psychological burden of receiving
trial results.
With regard to the practicalities of results feedback the ﬁndings
from this survey also highlight a number of differences in the
beliefs and attitudes of NCRI members and trial participants. In
particular there were noticeable differences in the attitudes of NCRI
members and patients towards the timing and mode of feedback
delivery.
Timing of results feedback
Whilst NCRI members showed a preference for providing
feedback after trial closure, the patient respondents were more
likely to endorse the provision of results at the end of an individ-
ual’s trial participation and/or a system of regular trial updates. This
may reﬂect a tendency for clinicians to consider trial results as the
published ﬁndings where as patients may consider that ‘results’
include other aspects of the trial such as ﬁnding out which arm of
the trial they were allocated to or being told how the trial is pro-
gressing in terms of recruitment and retention. A study conducted
by Fernandez et al. (2007), in which potential trial participants
were asked to indicate when they thought results should be shared
with participants, notes only a single individual (out of 40) selected‘while the study is still going on’. The majority acknowledged the
need for peer-review before disclosure (60%), but did not want “to
be the last to know” (Fernandez et al., 2007, p. 441). Whilst in
Richard et al.’s (2003) study of genetic breast cancer, several
women stated that the reason they wished to know results was in
order to discover whether they had the BRCA1/2 gene for breast
cancer. In other studies respondents wanted to knowwhether their
trial arm allocation had affected their own health (Dixon-Woods
et al., 2006). In our survey trial participants, along with express-
ing a desire for overall ﬁndings, also indicated a desire for personal
information relating to their treatment and for practical informa-
tion about the trial, such as howmany people had been recruited. It
may therefore be important to ensure that participants of trials are
not only offered the overall ﬁndings, but that they are also offered
the more personal and practical information that they may desire
during the course of the trial.
Mode of results feedback
Existing literature highlights that investigators perceive the
likely resource cost of offering/providing results to be a barrier
to the return of results (Partridge et al., 2004; MacNeil and
Fernandez, 2007). The survey data collected in this study appears
to have reﬂected this concern with NCRI members expressing
a preference for written feedback. In contrast the patients surveyed
expressed a desire for face-to-face feedback, placing value on
receiving the results in person, from someone who they knew from
the trial and of whom they could ask questions. However previous
research has demonstrated that receiving results in written from
can be acceptable to trial participants (Partridge et al., 2009) and it
has been suggested that receiving results in written form was
thought by some to be preferable to personal contact because they
could studywrittenmaterial at length and inprivate,without fear of
forgetting the content of a verbal communication (Dixon-Woods
et al., 2006). Mancini et al. (2010) have recently explored the use
of the internet as a means to communicate trial results and
demonstrated that greater accuracy in the understanding of trial
results existed amongst those who had received the results via the
internet, in comparison to a control group (Mancini et al., 2010).
In studies where respondents have not been given results, postal
results were also acceptable to many, but a substantial proportion
wanted to be given results face-to-face (Johnson et al., 2008;
Partridge et al., 2003; Kirschen et al., 2006), especially where
results had negative implications (Fernandez et al., 2009). Further
research is needed to identify a method or methods for providing-
resultswhichmeet the requirements of both clinicians and patients.
Finally,weacknowledgeanumberof limitationsof thiswork. First,
the response rate for the patient survey was over 50%. More disap-
pointingwas the return rate of just over 32% for the NCRI CSG survey.
Inadditionthisworkconcentratedonfeedbackof results in relation to
cancer trials in theUK. It is acknowledged that furtherwork intoother
health conditions and cultural backgrounds is required in order to
establish a greater understanding of the issues associated with the
practice of feeding back trial results in other populations.
Conclusion
There is growing support for the idea of communicating overall
results to participants after a research study has ended. What is still
unknown is the best and most effective way to do this (which, as
Shalowitz and Miller (2008) note, is also likely to vary according to
the type of trial and its outcomes) and the potential harm and
beneﬁts that such disclosure might elicit. Further research is
required.We support the suggestions of Shalowitz andMiller (2008)
that most informative would be research showing the resource costs
K. Cox et al. / European Journal of Oncology Nursing 15 (2011) 124e129 129and effects on patients of various feedback alternatives, as well as
outcomes in terms of satisfaction, understanding, and trial percep-
tions/behavioural intentions, including willingness to participate
again and/or recommend trials to others. Related feasibility work
would help to answer questions about the data management
required to track patients after the end of active participation in
order to be able to return results to those who wish to receive them.
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